I am a
Home I AM A Search Login

Papers of the Week

Papers: 27 Mar 2021 - 2 Apr 2021

Human Studies, Pharmacology/Drug Development

2021 Mar 30

J Headache Pain



Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.


Smith TR, Spierings ELH, Cady R, Hirman J, Schaeffler B, Shen V, Sperling B, Brevig T, Josiassen M K, Brunner E, Honeywell L, Mehta L
J Headache Pain. 2021 Mar 30; 22(1):16.
PMID: 33781209.


The humanized anti-CGRP monoclonal antibody eptinezumab has been evaluated in five large-scale clinical trials conducted in patients with migraine. This integrated analysis was conducted to evaluate the comprehensive safety and tolerability of eptinezumab in patients with migraine across these studies.